Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Diclofenac / misoprostol price, strengths & recalls

Generic of Arthrotec

Pharmacies pay $31.49 for 30 tablets of Diclofenac / misoprostol 75 mg / 0.2 mg delayed-release tablet this week, and from $23.25 to $31.49 across its 2 priced strengths and forms. 9 manufacturers make it. It has 7 recalls on record, none ongoing. Its official label last changed on March 26, 2026.

Generic
Pharmacies pay$31.49for 30 tablets of 75 mg / 0.2 mg delayed-release tablet+8.6% in 4 weeks
Fair cash price
$46.71
Strengths
2
Makers
9
Updated
Nov 11

Diclofenac / misoprostol price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
50 mg / 0.2 mg delayed-release tablet$0.7750$23.25 / 30 tablets+16.6%-10.4%
75 mg / 0.2 mg delayed-release tablet$1.05$31.49 / 30 tablets+8.6%+2.9%

Brand names of diclofenac / misoprostol

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 17, 2026
No ongoing recalls7 recalls on record, latest Dec 3, 2014

Recalls

Showing the 6 most relevant of 7 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for diclofenac / misoprostol? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMarch 26, 2026
Version1
EffectiveMar 24, 2026
Read the label

These highlights do not include all the information needed to use DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS. DICLOFENAC SODIUM and MISOPROSTOL delayed-release tablets, for oral use Initial U.S. Approval: 1997

This drug has a boxed warning

WARNING: RISK OF UTERINE RUPTURE, ABORTION, PREMATURE BIRTH, BIRTH DEFECTS; SERIOUS CARDIOVASCULAR EVENTS; AND SERIOUS GASTROINTESTINAL EVENTS

Uterine Rupture, Abortion, Premature Birth, and Birth Defects

Administration of misoprostol, a component ofdiclofenac sodium and misoprostol delayed-release tablets, to pregnant women can cause uterine rupture, abortion, premature birth, or birth defects. Uterine rupture has occurred when misoprostol was administered in pregnant women to induce labor or an abortion

[see Warnings and Precautions (

5.1) and Use in Specific Populations (

8.1)]

.

Diclofenac sodium and misoprostol delayed-release tabletsare contraindicated in pregnancy

[see Contraindications (

4)]

and not recommended in women of childbearing potential. Patients must be advised of the abortifacient property and warned not to give the drug to others

[see Warnings and Precautions (

5.1)]

.

Ifdiclofenac sodium and misoprostol delayed-release tabletsare prescribed, verify the pregnancy status of females of reproductive potential prior to initiation of treatment and advise them to use effective contraception during treatment

[see Use in Specific Populations (

8.3)].

Cardiovascular Thrombotic Events

NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use

[see Warnings and Precautions (

5.2)]

.

Diclofenac sodium and misoprostol delayed-release tabletsare contraindicated in the setting of coronary artery bypass graft (CABG) surgery

[see Contraindications (

4) and Warnings and Precautions (

5.2)].

Gastrointestinal Bleeding, Ulceration, and Perforation

NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events

[see Warnings and Precautions (

5.3)]

.

WARNING: RISK OF UTERINE RUPTURE, ABORTION, PREMATURE BIRTH, BIRTH DEFECTS; SERIOUS CARDIOVASCULAR EVENTS; AND SERIOUS GASTROINTESTINAL EVENTS

See full prescribing information for complete boxed warning.

Administration of misoprostol, a component of diclofenac sodium and misoprostol delayed-release tablets, to pregnant women can cause uterine rupture, abortion, premature birth, or birth defects. Uterine rupture has occurred when misoprostol was administered in pregnant women to induce labor or an abortion. (

4,

5.1,

8.1)

Diclofenac sodium and misoprostol delayed-release tablets are contraindicated in pregnancy and is not recommended in women of childbearing potential. Patients must be advised of the abortifacient property and warned not to give the drug to others. (

5.1,

8.3)

Increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. (

5.2)

Diclofenac sodium and misoprostol delayed-release tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery. (

4,

5.2)

Increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal and can occur at any time and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk. (

5.3)

Recent major changes (as listed on the label)

Warnings and Precautions, Serious Skin Reactions (5.10) 11/2024

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA020607 · Pfizer
First approved
December 24, 1997 (29 years ago)
Latest approved change
November 21, 2024
Approved label
PDF, Nov 25, 2024
Generic makers
4 approved generic applications on the market

Diclofenac / misoprostol questions

How much does diclofenac / misoprostol cost without insurance?

Pharmacies pay about $31.49 for 30 tablets of diclofenac / misoprostol 75 mg / 0.2 mg delayed-release tablet ($1.05 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $46.71. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of diclofenac / misoprostol?

Diclofenac / misoprostol is sold as Arthrotec. The generic has the same active ingredient and usually costs far less.

Is diclofenac / misoprostol in shortage?

No shortage is reported for diclofenac / misoprostol right now. We check the national shortage list every day.

Has diclofenac / misoprostol been recalled?

7 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the diclofenac / misoprostol label last change?

The official label was last updated on March 26, 2026 (version 1). See what changed.

Talk about diclofenac / misoprostol

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.